Elizabeth Ireland

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

R. Charles Coombes, CF Snowdon, Robert Paridaens et al. · The Lancet · 2007 · 909 citations

Medicine, Endocrinology, Oncology +4

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

J. Floege, Jae Bum Kim, Elizabeth Ireland et al. · Nephrology Dialysis Transplantation · 2010 · 475 citations · Full text

Medicine, Endocrinology, Nephrology +17

Hemoglobin Variability Does Not Predict Mortality in European Hemodialysis Patients

Kai‐Uwe Eckardt, Joseph Kim, Florian Kronenberg et al. · Journal of the American Society of Nephrology · 2010 · 67 citations · Full text

Medicine, Hematology, Nephrology +15

Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES)—a randomised controlled trial of exemestane versus continued tamoxifen after 2–3 years tamoxifen

Gianfilippo Bertelli, Emma Hall, Elizabeth Ireland et al. · Annals of Oncology · 2009 · 41 citations · Full text

Medicine, Gynecology, Oncology +9